Analysts Raise Avalara’s Price Target Following Q2 Earnings Beat
Raymond James analyst Brian Peterson raised the price target on Avalara Inc (NYSE:AVLR) to $220 from $155, implying a 29.7% upside, and reiterated…
Synaptics Shares Pop As Analysts Hail Its Q4 Earnings Beat, Raise Price Target
Needham analyst Rajvindra Gill raised the price target on Synaptics Inc (NASDAQ:SYNA) to $220 from $200, implying a 50.3% upside, and maintained a Buy…
Yelp Shares Gain As Analysts Remain Divided Following Q2 Earnings Beat
Credit Suisse analyst Stephen Ju raised the price target on Yelp Inc (NYSE:YELP) to $53 from $43, implying a 42.5% upside, and reiterated an…
Tigress Financial Reiterates Buy on Caterpillar, Announces $270 Price Target
Tigress Financial analyst Ivan Feinseth reiterates Caterpillar (NYSE:CAT) with a Buy and announces $270 price target.
3 Etsy Analysts On Q2 Earnings, ‘Softer Than Expected’ Q3 Guidance
Etsy analysts are reacting to the e-commerce platform's second-quarter earnings report and third-quarter guidance.
Why Nikola Has ‘Everest-Like’ Uphill Challenges To Turn Investor Sentiment Around
Nikola Corporation (NASDAQ: NKLA) reported forecast-beating bottom-line results on Tuesday.
3 Alibaba Analysts Say Valuation Is Attractive Despite Q1 Disappointment
Alibaba Group Holding Limited (NASDAQ: BABA) reported June quarter results Tuesday, sending the Chinese e-commerce company's stock lowe
Take Two Interactive May Be ‘One Of ‘Best In Video Game Sector,’ But What Do These 3 Analysts Think?
Analysts reacted to the first-quarter earnings report of Take-Two Interactive Software Inc (NASDAQ: TTWO) and shared thoughts on the pipeline of content to come.
PreMarket Prep Stock Of The Day: Chevron
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.
TG Therapeutics Stock Plunged As H.C. Wainwright Cuts Target Price After Disappointing Q2
H.C. Wainwright has lowered TG Therapeutics Inc’s (NASDAQ:TGTX) price target to $84 from $89 and keeps a Buy rating on the stock. Analyst Edward…